Department of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia.
Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
FASEB J. 2022 Apr;36(4):e22215. doi: 10.1096/fj.202101056RR.
Clitocybe nebularis lectin (CNL) is a GalNAcβ1-4GlcNAc-binding lectin that exhibits an antiproliferative effect exclusively on the Jurkat leukemic T cell line by provoking homotypic aggregation and dose-dependent cell death. Cell death of Jurkat cells exhibited typical features of early apoptosis, but lacked the activation of initiating and executing caspases. None of the features of CNL-induced cell death were effectively blocked with the pan-caspase inhibitor or different cysteine peptidase inhibitors. Furthermore, CNL binding induced Jurkat cells to release the endogenous damage-associated molecular pattern molecule high-mobility group box 1 (HMGB1). A plant lectin with similar glycan-binding specificity, Wisteria floribunda agglutinin (WFA) showed less selective toxicity and induced cell death in Jurkat, Tall-104, and Hut-87 cell lines. HMGB1 release was also detected when Jurkat cells were treated with WFA. We identified the CD45 and CD43 cell surface glycoproteins on Jurkat cells as the main targets for CNL binding. However, the blockade of CD45 phosphatase activity failed to block either CNL-induced homotypic agglutination or cell death. Overall, our results indicate that CNL triggers atypical cell death selectively on Jurkat cells, suggesting the potential applicability of CNL in novel strategies for treating and/or detecting acute T cell leukemia.
云芝凝集素(CNL)是一种 GalNAcβ1-4GlcNAc 结合凝集素,它通过诱导同质聚集和剂量依赖性细胞死亡,对 Jurkat 白血病 T 细胞系表现出独特的抗增殖作用。Jurkat 细胞的死亡表现出典型的早期细胞凋亡特征,但缺乏起始和执行半胱天冬酶的激活。用泛半胱天冬酶抑制剂或不同的半胱氨酸肽酶抑制剂均不能有效阻断 CNL 诱导的细胞死亡的特征。此外,CNL 结合诱导 Jurkat 细胞释放内源性损伤相关分子模式分子高迁移率族蛋白 B1(HMGB1)。具有相似糖结合特异性的植物凝集素,紫藤凝集素(WFA)显示出较低的选择性毒性,并诱导 Jurkat、Tall-104 和 Hut-87 细胞系的细胞死亡。当用 WFA 处理 Jurkat 细胞时,也检测到 HMGB1 的释放。我们鉴定出 Jurkat 细胞表面的 CD45 和 CD43 细胞表面糖蛋白是 CNL 结合的主要靶标。然而,阻断 CD45 磷酸酶活性并不能阻止 CNL 诱导的同质聚集或细胞死亡。总的来说,我们的结果表明,CNL 选择性地触发 Jurkat 细胞发生非典型细胞死亡,提示 CNL 在治疗和/或检测急性 T 细胞白血病的新策略中具有潜在的适用性。